LAM Research (LRCX) Earns Buy Rating on Record $8.22B Q1 Revenue Despite Dip

LRCX earns a Buy rating in October 2026 after posting a record $8.22B in Q1 revenue. Despite a 9.6% post-earnings dip, strong AI demand and 52.4% gross margins present a compelling opportunity.

The Disconnect: Record Earnings Meet Market Skepticism Lam Research Corporation ( NASDAQ : LRCX) recently delivered the best quarter in its history, yet the market responded by punishing the stock with a roughly 9.6% pre-market selloff, driving shares down to $235.75. This sharp dissonance between record fundamental delivery and a post-earnings de-rating creates a compelling, albeit complex, investment setup. Despite the market's disappointment, a deep dive into the data suggests LRCX deserves a Buy rating, anchored by structural AI tailwinds and a more attractive valuation. Record Q1 Financials and the AI-Intensity Dividend Lam's fiscal Q1 2027 (September quarter) performance was nothing short of historic. The company showcased immense operational leverage and cash-generation capabilities: Revenue : A record $8.22 billion, up 54% year-over-year. Earnings Per Share (EPS): GAAP diluted EPS reached $2.19. Profitability: Non-GAAP gross margin hit 52.4%, and operating margin crossed the 40% threshold for the first time, landing at 40.2%. Free Cash Flow : A staggering $3.24 billion, representing 1.27x net income for the quarter. The underlying driver of this performance is Lam's deep economic moat in semiconductor equipment . The company holds an estimated 49%–51% share in conductor etch and over 75% in high-aspect-ratio 3D NAND etch. AI is structurally increasing the number of etch, deposition , and clean steps per wafer. During the quarter, Lam secured tool-of-record wins for all four of its backside-power products at a leading customer, proving that its served available market (SAM) is expanding alongside AI device complexity. The China Overhang: Unpacking the Market's Fears If the fundamentals are so strong, why did the stock drop? The market's skepticism is rooted in several near-term risks that lie beneath the headline numbers: Geographic Concentration : Revenue from China spiked to 35% in the September quarter (up from 26% in June). Management explicitly guided that China will be a "significantly lower percentage" of December revenue, creating a sharp regional-mix headwind. Lack of Visibility: No backlog or bookings were disclosed. Without this data, the market fears that the Q1 revenue surge was partly driven by customers pulling forward orders to secure scarce capacity, rather than a broadening order book. Margin Durability: The record 52.4% gross margin was aided by favorable China mix and supply constraints. Investors are questioning if these margins are structural or a cyclical illusion that will compress as China revenue normalizes. Valuation and the $200 Billion Multi-Year Cycle Despite these valid concerns, the post-earnings selloff has materially de-risked the stock's valuation. At the $235.75 reference price, Lam trades at approximately 25.2x forward fiscal 2027 consensus EPS of $9.34. This is a significantly less demanding entry point compared to its trailing 38.6x P/E . Furthermore, management's forward-looking commentary suggests this cycle has a long runway. Lam expects calendar-2027 wafer fabrication equipment ( WFE ) spending to exceed $200 billion, up from the mid-$150 billion range in 2026. With customer visibility extending through 2028 and a diversified demand architecture driven by hyperscaler capex , custom ASICs, and HBM3E /HBM4 transitions, the long-term growth narrative remains intact. The Verdict: A Medium-Conviction Buy LRCX earns a BUY rating with a 12-month base-case target of $262, representing an approximate +11% return from recent lows. The bull case ($330) implies a +40% upside if WFE exceeds $200 billion and margins hold , while the bear case ($135) reflects the severe risks of capacity digestion and worsening China restrictions. Because the probability-weighted 12-month value sits at roughly $237—modestly above current prices—this is a medium-conviction rating. The near-term risks of margin normalization and China step-downs are real, but for investors willing to navigate the volatility , Lam Research remains one of the most fundamentally powerful semiconductor-equipment compounders in the AI era. Disclaimer: This content is generated by AI. While we strive to ensure accuracy, please use this information for educational purposes only.